In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, talks about inflammatory biomarkers of mortality in women with stroke and rheumatoid arthritis, including whether stroke history modifies the effect of...
In this podcast, Georg Schett, MD, discusses the results and implications of his team’s recent study examining the tapering or stopping of medication in patients with rheumatoid arthritis who achieve stable...
Dr Winthrop talks about how vaccinations affect individuals with immunocompromised immune systems, the challenges associated with vaccination, and what rheumatologists should know about vaccines in 2020. ...
Dr Karpouzas discusses his research that evaluated whether β-2 glycoprotein 1 IgA antibodies can predict coronary plaque burden and progression, and whether the antibodies moderate the effect of...
Dr Karpouzas talks about his study that evaluated whether biologic disease-modifying antirheumatic drugs reduce long-term risk of cardiovascular events in patients with rheumatoid arthritis, as well as...
Dr Karpouzas talks about his study that evaluated the influence of distinct domains of rheumatoid arthritis disease activity, functional limitation, mood disturbance, as well as RA-specific knowledge...
In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, speaks about how gender modifies the effect of rheumatoid arthritis on all-cause mortality and why rheumatoid arthritis is underdiagnosed.
Dr Barber discusses the lessons learned from her research into the use of patient aids and shared decision making among patients with rheumatoid arthritis and their health care providers.
Dr Karpouzas talks about his study that evaluated the impact of inflammation, cardiac risk factors, duration of medication exposure, and their interactions on coronary plaque progression among patients...
